Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carvana
CVNA
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$727M |
| 3 |
Amazon
AMZN
|
+$478M |
| 4 |
PayPal
PYPL
|
+$450M |
| 5 |
Apple
AAPL
|
+$448M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$800M |
| 2 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$610M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$483M |
| 4 |
Boston Scientific
BSX
|
+$211M |
| 5 |
Fidelity High Dividend ETF
FDVV
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Financials | 6.13% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Healthcare | 5.03% |
| 5 | Communication Services | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
National Health Investors
NHI
$3.68B
| $4.51M | ﹤0.01% |
78,490
-9,277
| -11% | -$513K |
|
1902
OneSpan
OSPN
$588M
| $4.51M | ﹤0.01% |
266,320
+25,286
| +10% | +$472K |
|
1903
Erie Indemnity
ERIE
$12.4B
| $4.5M | ﹤0.01% |
23,364
-6,827
| -23% | -$1.37M |
|
1904
Vishay Intertechnology
VSH
$5.43B
| $4.49M | ﹤0.01% |
205,452
-53,784
| -21% | -$1.1M |
|
1905
Appian
APPN
$2.03B
| $4.49M | ﹤0.01% |
68,799
+21,106
| +44% | +$1.75M |
|
1906
Travere Therapeutics
TVTX
$5.11B
| $4.48M | ﹤0.01% |
144,384
-91,443
| -39% | -$2.58M |
|
|
CNDB.U
1907
DELISTED
Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
CNDB.U
| $4.48M | ﹤0.01% |
+439,524
| New | +$4.47M |
|
|
VERV
1908
DELISTED
Verve Therapeutics
VERV
| $4.47M | ﹤0.01% |
121,157
+119,343
| +6,579% | +$5.01M |
|
1909
PUT
Baidu
BIDU
$38.3B
| $4.46M | ﹤0.01% |
30,000
-41,000
| -58% | -$6.4M |
|
1910
Voya Financial
VOYA
$9.07B
| $4.46M | ﹤0.01% |
67,273
-119,974
| -64% | -$7.9M |
|
1911
Tetra Tech
TTEK
$8.66B
| $4.45M | ﹤0.01% |
131,020
+43,680
| +50% | +$1.5M |
|
1912
CALL
Nutrien
NTR
$31.7B
| $4.45M | ﹤0.01% |
59,100
-10,900
| -16% | -$763K |
|
|
GXDW
1913
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$6.13M
| $4.45M | ﹤0.01% |
100,000
| – | – |
|
|
HES
1914
PUT
DELISTED
Hess
HES
| $4.44M | ﹤0.01% |
60,000
+36,200
| +152% | +$2.94M |
|
|
NBIS
1915
Nebius Group N.V.
NBIS
$54B
| $4.43M | ﹤0.01% |
73,223
-93,693
| -56% | -$6.9M |
|
1916
CACI
CACI
$11.3B
| $4.43M | ﹤0.01% |
16,447
-1,071
| -6% | -$293K |
|
1917
SentinelOne
S
$6.87B
| $4.43M | ﹤0.01% |
87,653
+52,612
| +150% | +$3.08M |
|
|
TELL
1918
DELISTED
Tellurian Inc.
TELL
| $4.42M | ﹤0.01% |
1,435,746
+35,608
| +3% | +$126K |
|
|
PING
1919
DELISTED
Ping Identity Holding Corp.
PING
| $4.42M | ﹤0.01% |
193,279
+10,990
| +6% | +$280K |
|
1920
Mitek Systems
MITK
$767M
| $4.41M | ﹤0.01% |
248,663
+3,200
| +1% | +$57.2K |
|
1921
Arcus Biosciences
RCUS
$3.47B
| $4.41M | ﹤0.01% |
108,900
+46,415
| +74% | +$1.8M |
|
1922
CALL
Aflac
AFL
$64.5B
| $4.38M | ﹤0.01% |
75,000
| – | – |
|
|
OMP
1923
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $4.38M | ﹤0.01% |
183,093
-12,716
| -6% | -$300K |
|
|
CVAC
1924
PUT
DELISTED
CureVac
CVAC
| $4.38M | ﹤0.01% |
127,500
-81,800
| -39% | -$3.29M |
|
1925
PUT
Marvell Technology
MRVL
$174B
| $4.38M | ﹤0.01% |
+50,000
| New | +$3.73M |
|
Similar funds
Citigroup's Q4 2021 Portfolio in Review
As of Q4 2021, Citigroup held 6,293 positions worth $187B, up 10% from $169B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $6.91B of net new capital in Q4 2021, opening 489 new positions and adding to 2,934 existing holdings. Its largest new stake was Nu Holdings: 27,608,577 shares worth $259M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $800M trimmed.
- Citigroup's largest Q4 2021 buy was Nu Holdings: 27,608,577 shares worth $259M.
- Citigroup added most to Carvana in Q4 2021, an estimated $1.01B increase.
- Citigroup's biggest Q4 2021 reduction was Invesco QQQ Trust, cutting an estimated $800M.
- Citigroup fully exited ProShares UltraPro Short QQQ in Q4 2021, selling an estimated $149M.
- Citigroup's ten largest holdings make up 25% of its $187B portfolio in Q4 2021.
- Citigroup opened 489 new positions and closed 426 in Q4 2021.
- Citigroup's portfolio value rose 10% quarter-over-quarter to $187B.
Based on Citigroup's 13F filing for Q4 2021, filed 10 Feb 2022.